Article Figures & Data
Tables
Retinopathy type Low-risk (HbA1c ≤7) n=327 (76.4) High-risk (HbA1c ≥9) n=101 (23.6) P-value DR No 255 (77.9) 12 (11.9) <0.001 Yes 72 (22.1) 89 (88.1) NPDR Mild 34 (47.2) 44 (49.4) 0.129 Moderate 26 (36.1) 17 (19.1) Severe 8 (11.1) 13 (14.6) PDR No 68 (94.4) 74 (83.1) 0.340 Yes 4 (5.6) 15 (16.9) MO No 311 (95.1) 85 (84.1) <0.001 Yes 16 (4.9) 16 (15.8) CSMO No 325 (99.4) 93 (92.1) <0.001 Yes 2 (0.6) 8 (7.9) Values are presented as numbers and percentages (%). HbA1c: hemoglobin A1c, DR: diabetic retinopathy, NPDR: non-proliferative DR, PDR: proliferative DR, MO: macular oedema, CSMO: clinically significant MO
- Table 2
- Comparison of baseline demographics and clinical characteristics of the participants (N=428).
Variables Low-risk (HbA1c ≤7) High-risk (HbA1c ≥9) P-value Mean±SD Mean±SD Age (years) 61.3±11.5 60.1±10.1 0.327 BMI (kg/m2) 32.6±7.0 33.6±6.6 0.279 SBP (mmHg) 125.9±16.2 126.6±16.8 0.683 DBP (mmHg) 65.6±10.7 65.5±11.0 0.944 LDL (mmol/L) 2.34±0.79 2.75±0.98 <0.001 Albumin to creatinine ratio 12.3±39.7 16.6±67.8 0.599 Diabetes duration (years) 13.2±7.2 13.3±7.2 0.886 eGFR (ml/min/1.73 m2) 85.07±22.39 87.21±24.95 0.451 Gender Male 114 (34.9) (35) (34.7) 0.969 Female 213 (65.1) 66 (65.3) Smoker No 309 (96.9) 96 (97.0) 0.958 Yes 10 (3.1) 3 (3.0) ACEi and ARB use No 68 (22.0) 25 (25.8) 0.441 Yes 241 (78.0) 72 (74.2) Statin use No 25 (8.1) 3 (3.1) 0.093 Yes 283 (91.9) 93 (96.9) Values are presented as numbers and percentages (%). BMI: body mass index; SBP: systolic blood pressure, DBP: diastolic blood pressure, LDL: low-density lipoprotein, eGFR: estimated glomerular filtration rate, ACEI: angiotensin converting enzyme inhibitors, ARBs: angiotensin-receptor blockers
- Table 3
- Multivariate analysis for the factors that are potentially associated with diabetic retinopathy by risk group.
Low-risk(HbA1c ≤7) High-risk(HbA1c ≥9) aOR LowerCI UpperCI P-value aOR LowerCI Upper CI P-value Age 1.012 0.990 1.036 0.284 0.970 0.911 1.033 0.338 BMI 1.014 0.968 1.061 0.566 1.021 0.917 1.137 0.701 Gender 0.611 0.359 1.040 0.069 1.123 0.304 4.151 0.862 SBP 1.008 0.992 1.024 0.340 0.996 0.959 1.034 0.825 DBP 0.988 0.964 1.013 0.340 1.028 0.967 1.094 0.375 HbA1c (last 12 months) 0.712 0.383 1.321 0.281 1.096 0.645 1.863 0.733 LDL 1.007 0.712 1.423 0.970 1.145 0.564 2.328 0.708 Albumin to creatinine ratio 0.993 0.972 1.014 0.485 1.225 0.781 1.923 0.377 Diabetes duration 1.025 0.989 1.062 0.173 0.998 0.915 1.090 0.972 ACEI/ARB use 0.819 0.416 1.609 0.562 1.524 0.305 7.626 0.608 Annual eGFR 0.997 0.985 1.009 0.593 0.992 0.965 1.020 0.555 Abbreviations, as in Table 2; aOR: adjusted odds ratio, CI: confidence interval, LDL: low-density lipoprotein, DBP: diastolic blood pressure, HbA1c: hemoglobin A1c, ACEI: angiotensin converting enzyme inhibitors, ARBs: angiotensin-receptor blockers, BMI: body mass index, SBP: systolic blood pressure,